Weight Loss with VLCAD Deficiency in South Africa

Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency is one of the most clinically significant fatty acid oxidation disorders diagnosed on newborn screening in South Africa. If you or your child has been diagnosed with VLCAD Deficiency and you are looking to manage body weight, understanding how long-chain fat metabolism works — and where it breaks down — is essential. This guide explains the biochemistry in plain language, identifies which dietary strategies carry serious risk, and outlines how to safely approach a caloric deficit under metabolic team guidance.

What Is VLCAD Deficiency?

VLCAD Deficiency is caused by mutations in the ACADVL gene, which encodes the very long-chain acyl-CoA dehydrogenase enzyme. This enzyme sits in the inner mitochondrial membrane and catalyses the first step of beta-oxidation for long-chain fatty acids with carbon chain lengths of 14 to 22 carbons (C14–C22). These are the fats found in most dietary fat sources — olive oil, sunflower oil, animal fats, dairy fat, and the fat in meat and fish.

When the VLCAD enzyme is absent or severely reduced, the body cannot enter very long-chain fats into the beta-oxidation cycle to generate acetyl-CoA and ATP. Instead, long-chain acylcarnitines accumulate. The characteristic marker on acylcarnitine analysis is elevated C14:1 (tetradecenoylcarnitine), which is the primary newborn screening marker for VLCAD Deficiency. Secondary elevations in C14, C14:2, and C16 acylcarnitines are also typical.

VLCAD Deficiency sits in the same disease family as MCAD Deficiency and LCHAD Deficiency but carries distinct features. Unlike MCAD Deficiency (which affects medium-chain fats C6–C12), VLCAD Deficiency affects longer chains and carries a higher risk of cardiomyopathy and severe exercise-induced myopathy. Unlike LCHAD Deficiency, retinal degeneration and peripheral neuropathy are less prominent, though cardiac involvement is more frequent in severe VLCAD phenotypes.

The Three Clinical Phenotypes

VLCAD Deficiency presents across a wide severity spectrum, which directly determines how aggressive or conservative your weight management approach must be:

• Severe cardiac phenotype (neonatal onset): Presents in the first days to weeks of life with hypertrophic cardiomyopathy, pericardial effusion, arrhythmia, and hypoglycaemia. Life-threatening without immediate dietary intervention. Survivors require lifelong very low LCT diet with MCT supplementation.
• Hepatic/hypoglycaemic phenotype (infantile onset): Presents in infancy with hypoketotic hypoglycaemia during fasting or illness, hepatomegaly, and elevated liver enzymes. Fasting avoidance is the primary management pillar.
• Myopathic phenotype (adolescent/adult onset): The mildest phenotype. Presents with exercise-induced muscle pain, rhabdomyolysis, and myoglobinuria triggered by prolonged or intense physical activity. Dietary fat restriction is less extreme than in the cardiac phenotype, but exercise management is critical.

Many South Africans diagnosed through expanded newborn screening are mild phenotypes who would not have presented clinically until adulthood. Your phenotype classification from your metabolic team determines your dietary boundaries.

Why Standard High-Fat and Ketogenic Diets Are Dangerous

VLCAD Deficiency is one condition where the popular high-fat, low-carbohydrate, and ketogenic weight loss approaches carry direct biochemical risk:

• High-fat meals flood the blocked pathway: Long-chain dietary fats (LCT) are the direct substrate that VLCAD cannot process. A high-fat meal in a person with severe VLCAD Deficiency generates large amounts of C14–C22 acylcarnitines that accumulate in cardiac and skeletal muscle, disrupting membrane function and contributing to arrhythmia and myopathy.
• Ketogenic diets are contraindicated in moderate-to-severe VLCAD: A ketogenic diet derives 70–80% of calories from fat — predominantly long-chain fats. This creates a sustained, high-flux load through the blocked step, generating toxic acylcarnitine accumulation. The body in ketosis also relies heavily on fatty acid oxidation for fuel, which is precisely what VLCAD patients cannot do efficiently.
• Fasting triggers hypoketotic hypoglycaemia: During fasting, the body shifts from glucose to fat as its primary fuel. In VLCAD Deficiency, long-chain fat oxidation is impaired, so the liver cannot generate ketones adequately. Hypoglycaemia results — without the protective ketone elevation that normally accompanies fasting in healthy individuals. This is the same mechanism as in MCAD Deficiency, but VLCAD is additionally complicated by the cardiac and myopathic risks.

The MCT Oil Strategy: Your Metabolic Bypass

Medium-chain triglycerides (MCT oil) are the cornerstone of VLCAD Deficiency management and the key to achieving any sustainable caloric deficit. MCTs (C8:0 caprylic acid and C10:0 capric acid) bypass the VLCAD enzyme entirely — they are oxidised by the MCAD enzyme and shorter-chain enzymes, which are unaffected in VLCAD Deficiency.

This means MCT oil can provide fat-derived energy, ketones, and satiety without loading the blocked pathway. In practical terms:

• MCT oil replaces long-chain cooking oils in food preparation where possible. Stir-frying with MCT oil rather than sunflower or olive oil provides fat-derived energy via a safe route.
• MCT oil can be added to rooibos tea, smoothies, or porridge as a calorie-dense but metabolically safe energy source when LCT intake is being reduced.
• Specialised VLCAD medical formulas (prescribed through your metabolic team and available through certain South African pharmacies and dietetic suppliers) provide MCT-based fat alongside essential fatty acids and micronutrients.

However, MCT oil is still a concentrated calorie source (approximately 120 kcal per 15 ml tablespoon). If you are trying to create a caloric deficit for weight loss, MCT oil quantities need to be counted in your total calorie budget. Your metabolic dietitian will calculate your safe MCT allocation.

Dietary LCT Restriction: Practical SA Foods

For moderate-to-severe VLCAD phenotypes, long-chain fat (LCT) intake is restricted to a prescribed gram target — often 10–20 g LCT per day for severe cardiac phenotypes, or up to 30–40 g LCT per day for milder phenotypes. This requires understanding which SA foods are high or low in long-chain fats:

• High LCT (restricted): Biltong and droewors (fatty cuts), boerewors, full-fat dairy (milk, cheese, amasi), eggs (yolk), avocado, sunflower oil, olive oil, butter, margarines, coconut oil (contains C12 lauric acid which has partial long-chain properties), fatty fish (pilchards, sardines), peanut butter in large quantities.
• Lower LCT (preferred): Very lean cuts of chicken breast (skinless), very lean beef fillet, white fish (hake, kingklip), legumes (lentils, sugar beans, chickpeas), maize meal, brown rice, sweet potato, vegetables, fruit, low-fat milk and low-fat amasi if tolerated within your LCT budget.
• MCT-safe fats: MCT oil (prescribed quantities), MCT-enriched formula products.

Note that essential fatty acids (omega-3 and omega-6 long-chain polyunsaturated fats) cannot be eliminated entirely. Your metabolic team will prescribe small amounts of essential fatty acid sources or a DHA/EPA supplement to prevent deficiency, even on a very low LCT diet.

Exercise and VLCAD Deficiency: The Rhabdomyolysis Risk

Exercise is one of the most powerful weight management tools — but in VLCAD Deficiency, physical activity carries a specific and serious risk: exercise-induced rhabdomyolysis.

During sustained aerobic exercise, working muscle relies heavily on long-chain fatty acid oxidation for fuel. In VLCAD Deficiency, this pathway is impaired, causing long-chain acylcarnitines to accumulate in muscle. This damages muscle cell membranes, releasing myoglobin into the bloodstream. Myoglobin in the kidneys causes acute kidney injury.

Warning signs of exercise-induced rhabdomyolysis:

• Muscle pain, cramps, or weakness during or after exercise — disproportionate to effort level
• Dark, tea-coloured, or red-brown urine after exercise (myoglobinuria) — this is an emergency
• Severe fatigue, nausea, or vomiting after physical activity

If dark urine appears after exercise, go to an emergency room immediately. Rhabdomyolysis can cause acute kidney failure if not treated promptly with intravenous fluid.

Safe exercise for VLCAD Deficiency:

• Short-duration, low-intensity activities are generally better tolerated. Walking, gentle yoga, and light resistance training carry lower risk than running, cycling, or team sports.
• Eat a carbohydrate-rich snack before exercise to ensure glucose availability, reducing reliance on fat oxidation during activity.
• Stay well hydrated during exercise.
• Never exercise in a fasted state.
• Increase exercise intensity gradually and stop at any sign of unusual muscle pain or weakness.
• Discuss an individualised exercise programme with your metabolic team before starting any regular exercise for weight loss.

A Safe Caloric Deficit: How Much Can You Cut?

With your metabolic team's guidance, a caloric deficit is achievable in VLCAD Deficiency — the key is ensuring the deficit comes from carbohydrate and/or safe fat (MCT) reduction rather than creating a situation where the body catabolises its own long-chain fat stores excessively.

• Severe cardiac/hepatic phenotype: A deficit of 200–300 kcal/day maximum is conservative and appropriate. Prioritise reducing refined carbohydrates (white bread, sugary drinks, biscuits) while maintaining LCT below your prescribed ceiling and keeping MCT intake at your prescribed level. Meal frequency of 5–6 smaller meals prevents fasting periods and hypoketotic hypoglycaemia.
• Mild myopathic phenotype: A deficit of 300–500 kcal/day is often achievable. The LCT restriction is less extreme. Focus on carbohydrate portion control (maize meal, rice, bread) while ensuring adequate protein (lean chicken, fish, legumes) and regular meal spacing.
• All phenotypes: Never skip meals. Never fast beyond 10–12 hours without medical supervision. A bedtime carbohydrate snack (whole-grain rusk, low-fat milk with a slice of toast) prevents the overnight fasting period from extending into a metabolically dangerous zone.

Monitoring and Medical Team

Weight loss in VLCAD Deficiency requires active collaboration with your metabolic team:

• Acylcarnitine profiles should be monitored periodically during dietary changes to ensure C14:1 levels are not rising, which would indicate increased flux through the blocked pathway.
• Cardiac function (ECG, echocardiogram) should be monitored in patients with a history of cardiomyopathy, as metabolic stress during aggressive dietary changes can affect heart function.
• Creatine kinase (CK) levels before and after exercise can help identify subclinical myopathy.
• Annual review with a metabolic dietitian is recommended; more frequent review during active weight loss programmes.

In South Africa, metabolic services for fatty acid oxidation disorders are available at major academic hospitals including Red Cross War Memorial Children's Hospital (Cape Town), Charlotte Maxeke Johannesburg Academic Hospital, Steve Biko Academic Hospital (Pretoria), and Inkosi Albert Luthuli Central Hospital (Durban). Adults with VLCAD Deficiency often transition to internal medicine specialists with metabolic experience.

Practical Daily Meal Structure

A sample day for a mild-to-moderate VLCAD phenotype targeting a 300 kcal deficit:

• Breakfast: Oats cooked with water or low-fat milk, with a teaspoon of MCT oil stirred in, topped with banana and a small drizzle of honey. A rooibos tea alongside.
• Mid-morning snack: A small portion of low-fat amasi with a handful of bran cereal.
• Lunch: Grilled skinless chicken breast with brown rice and a large portion of roasted vegetables (butternut, carrots, peas). Avoid adding oil beyond a small MCT oil measure.
• Afternoon snack: Two provitas or rice cakes with a scraping of reduced-fat cottage cheese.
• Dinner: Baked hake with maize meal pap and a large mixed salad with lemon juice dressing (no olive oil).
• Bedtime snack (mandatory): A slice of whole-grain toast with low-fat cottage cheese, or a small cup of low-fat milk with a single plain rusk — to prevent the overnight fasting period from extending dangerously.

Summary

VLCAD Deficiency makes standard high-fat and ketogenic weight loss approaches dangerous, but safe weight management is achievable with the right structure. The core principles are: restrict long-chain dietary fats (LCT) to your prescribed ceiling, use MCT oil as your metabolic bypass, never fast beyond 10–12 hours, fuel up before any exercise, and watch for dark urine as a rhabdomyolysis warning sign. A deficit of 200–500 kcal/day depending on phenotype severity — achieved through carbohydrate portion control and MCT optimisation — is a realistic and safe target under metabolic team guidance. Always consult your metabolic physician and dietitian before making any dietary changes.

This article is for informational purposes only and does not constitute medical advice. All dietary changes for VLCAD Deficiency must be supervised by a qualified metabolic physician and dietitian.